Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?

Since dendritic cells operate as professional antigen-presenting cells (APCs) and hence are capable of jumpstarting the immune system, they have been exploited to develop a variety of immunotherapeutic regimens against cancer. In the few past years, myeloid-derived suppressor cells (MDSCs) have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Escors, David, Liechtenstein, Therese, Perez-Janices, Noemi, Schwarze, Julia, Dufait, Ines, Goyvaerts, Cleo, Lanna, Alessio, Arce, Frederick, Blanco-Luquin, Idoia, Kochan, Grazyna, Guerrero-Setas, David, Breckpot, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825722/
https://www.ncbi.nlm.nih.gov/pubmed/24244902
http://dx.doi.org/10.4161/onci.26148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825722/
https://www.ncbi.nlm.nih.gov/pubmed/24244902
http://dx.doi.org/10.4161/onci.26148

Ejemplares similares